Target
N-formyl peptide receptor 2
Ligand
BDBM350560
Substrate
n/a
Meas. Tech.
FLIPR
EC50
1700±n/a nM
Citation
 Beard, RLDonello, JEViswanath, V Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases US Patent  US10208071 Publication Date 2/19/2019 
Target
Name:
N-formyl peptide receptor 2
Synonyms:
ALXR, FPRL1, FPR2 | FMLP-related receptor I FMLP-R-I | FPR2 | FPR2_HUMAN | FPRH1 | FPRL1 | Formyl Peptide Receptor-Like 1 | HM63 | LXA4 receptor | LXA4R | Lipoxin A4 receptor | Lipoxin A4 receptor (LXA4) | RFP | hFPRL
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
38968.35
Organism:
Homo sapiens (Human)
Description:
P25090
Residue:
351
Sequence:
METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
  
Inhibitor
Name:
BDBM350560
Synonyms:
3-[(4- iodophenyl)carbamoyl]-7,7- dimethylbicyclo[2.2.1]heptane- 2-carboxylic acid | US10208071, Compound 22 | US10434112, Compound 22 | US10799518, Compound 22
Type:
Small organic molecule
Emp. Form.:
C17H20INO3
Mol. Mass.:
413.2501
SMILES:
CC1(C)C2CCC1C(C2C(O)=O)C(=O)Nc1ccc(I)cc1 |TLB:9:8:5.4:1,THB:12:7:5.4:1|
Structure:
Search PDB for entries with ligand similarity: